Mycotic aortic aneurysm due to intravesical BCG immunotherapy: Clinical manifestations and diagnostic challenges

Brittany J. Holmes, Richard W. LaRue, James Hamilton Black, Kim Dionne, Nicole M Parrish, Michael Melia

Research output: Contribution to journalArticle

Abstract

A live, attenuated form of Mycobacterium bovis, bacillus Calmette-Guérin (BCG), is commonly used as intravesical immunotherapy for non-invasive urothelial bladder carcinoma. While complications are rare, dissemination can occur. A case of mycotic aortic aneurysm following BCG administration with recovery of Mycobacterium bovis in culture is reported. A review of the published experience with this problem is also presented.

Original languageEnglish (US)
Pages (from-to)60-65
Number of pages6
JournalInternational Journal of Mycobacteriology
Volume3
Issue number1
DOIs
StatePublished - 2014

Fingerprint

Infected Aneurysm
Aortic Aneurysm
Mycobacterium bovis
Immunotherapy
Bacillus
Urinary Bladder
Carcinoma

Keywords

  • Aorta
  • Bacillus Calmette-Guérin (BCG)
  • Mycobacterium bovis
  • Mycotic aneurysm
  • Psoas muscle abscess

ASJC Scopus subject areas

  • Infectious Diseases
  • Microbiology (medical)

Cite this

Mycotic aortic aneurysm due to intravesical BCG immunotherapy : Clinical manifestations and diagnostic challenges. / Holmes, Brittany J.; LaRue, Richard W.; Black, James Hamilton; Dionne, Kim; Parrish, Nicole M; Melia, Michael.

In: International Journal of Mycobacteriology, Vol. 3, No. 1, 2014, p. 60-65.

Research output: Contribution to journalArticle

@article{60c89ab1a83f4d98b9ad40ec412365f8,
title = "Mycotic aortic aneurysm due to intravesical BCG immunotherapy: Clinical manifestations and diagnostic challenges",
abstract = "A live, attenuated form of Mycobacterium bovis, bacillus Calmette-Gu{\'e}rin (BCG), is commonly used as intravesical immunotherapy for non-invasive urothelial bladder carcinoma. While complications are rare, dissemination can occur. A case of mycotic aortic aneurysm following BCG administration with recovery of Mycobacterium bovis in culture is reported. A review of the published experience with this problem is also presented.",
keywords = "Aorta, Bacillus Calmette-Gu{\'e}rin (BCG), Mycobacterium bovis, Mycotic aneurysm, Psoas muscle abscess",
author = "Holmes, {Brittany J.} and LaRue, {Richard W.} and Black, {James Hamilton} and Kim Dionne and Parrish, {Nicole M} and Michael Melia",
year = "2014",
doi = "10.1016/j.ijmyco.2013.11.002",
language = "English (US)",
volume = "3",
pages = "60--65",
journal = "International Journal of Mycobacteriology",
issn = "2212-5531",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Mycotic aortic aneurysm due to intravesical BCG immunotherapy

T2 - Clinical manifestations and diagnostic challenges

AU - Holmes, Brittany J.

AU - LaRue, Richard W.

AU - Black, James Hamilton

AU - Dionne, Kim

AU - Parrish, Nicole M

AU - Melia, Michael

PY - 2014

Y1 - 2014

N2 - A live, attenuated form of Mycobacterium bovis, bacillus Calmette-Guérin (BCG), is commonly used as intravesical immunotherapy for non-invasive urothelial bladder carcinoma. While complications are rare, dissemination can occur. A case of mycotic aortic aneurysm following BCG administration with recovery of Mycobacterium bovis in culture is reported. A review of the published experience with this problem is also presented.

AB - A live, attenuated form of Mycobacterium bovis, bacillus Calmette-Guérin (BCG), is commonly used as intravesical immunotherapy for non-invasive urothelial bladder carcinoma. While complications are rare, dissemination can occur. A case of mycotic aortic aneurysm following BCG administration with recovery of Mycobacterium bovis in culture is reported. A review of the published experience with this problem is also presented.

KW - Aorta

KW - Bacillus Calmette-Guérin (BCG)

KW - Mycobacterium bovis

KW - Mycotic aneurysm

KW - Psoas muscle abscess

UR - http://www.scopus.com/inward/record.url?scp=84897047073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897047073&partnerID=8YFLogxK

U2 - 10.1016/j.ijmyco.2013.11.002

DO - 10.1016/j.ijmyco.2013.11.002

M3 - Article

AN - SCOPUS:84897047073

VL - 3

SP - 60

EP - 65

JO - International Journal of Mycobacteriology

JF - International Journal of Mycobacteriology

SN - 2212-5531

IS - 1

ER -